Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Aimfinity Investment I Subunit | AIMBU | Nov 13, 2024 | 11.64 | 0.00 |
Aimfinity Investment I Unit | AIMAU | Nov 13, 2024 | 11.60 | 0.00 |
Ainos | AIMD | Nov 13, 2024 | 0.49 | -1.23 |
Air Industries Group | AIRI | Nov 13, 2024 | 5.82 | -2.51 |
Air Lease A | AL | Nov 13, 2024 | 49.35 | +2.09 |
Air Lease Pref A | AL-A | Nov 13, 2024 | 25.18 | 0.00 |
Air Products And Chemicals | APD | Nov 13, 2024 | 312.89 | +0.57 |
Air T | AIRTP | Nov 13, 2024 | 18.32 | +0.96 |
Air T | AIRT | Nov 13, 2024 | 18.70 | +23.19 |
Air Transport Services Group | ATSG | Nov 13, 2024 | 22.07 | +0.27 |
Airbnb A | ABNB | Nov 13, 2024 | 132.76 | -0.33 |
Airgain | AIRG | Nov 13, 2024 | 9.35 | -9.14 |
AirNet Technology ADR | ANTE | Nov 13, 2024 | 0.63 | -15.17 |
AirSculpt Technologies | AIRS | Nov 13, 2024 | 7.41 | -7.14 |
Airship AI A | AISP | Nov 13, 2024 | 3.74 | +21.82 |
AIX ADR | AIFU | Nov 13, 2024 | 1.13 | 0.00 |
Akamai Technologies | AKAM | Nov 13, 2024 | 88.75 | -1.48 |
Akanda | AKAN | Nov 13, 2024 | 0.67 | -3.38 |
Akari Therapeutics ADR | AKTX | Nov 13, 2024 | 2.24 | -2.61 |
Akebia Therapeutics | AKBA | Nov 13, 2024 | 1.92 | -1.54 |
Akero Therapeutics | AKRO | Nov 13, 2024 | 30.97 | -4.35 |
Akoustis Technologies | AKTS | Nov 13, 2024 | 0.05 | -1.05 |
Akoya BioSciences | AKYA | Nov 13, 2024 | 3.21 | +0.63 |
Akso Health ADR | AHG | Nov 13, 2024 | 0.82 | +5.13 |
Alamo Group | ALG | Nov 13, 2024 | 195.52 | +1.69 |
Alamos Gold | AGI | Nov 13, 2024 | 17.77 | -0.95 |
Alarm.com | ALRM | Nov 13, 2024 | 60.95 | +0.74 |
Alarum Technologies ADR | ALAR | Nov 13, 2024 | 15.38 | +3.22 |
Alaska Air Group | ALK | Nov 13, 2024 | 51.67 | +0.43 |
Alaunos Therapeutics | TCRT | Nov 13, 2024 | 2.40 | -1.64 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.